SPRAVATO® Treatment
It is a ketamine-based and FDA-approved nasal spray prescription medication that is used to treat treatment-resistant depression (TRD) in adult patients. It works by targeting specific receptors in the brain and helps regulate mood.
What is SPRAVATO?
SPRAVATO (esketamine) is an FDA-approved nasal spray used in conjunction with an oral antidepressant for adults with treatment-resistant depression (TRD). It is derived from ketamine and works differently from traditional antidepressants, offering hope to patients who have not responded to other treatments.
SPRAVATO is administered in a certified healthcare setting under the supervision of a medical professional. Patients are monitored for at least two hours after each treatment session to ensure safety and comfort.
How SPRAVATO Works
Targets NMDA Receptors
Unlike traditional antidepressants that target serotonin or norepinephrine, SPRAVATO works on the NMDA glutamate receptor, helping to restore synaptic connections in the brain.
Rapid Onset of Action
Many patients begin to experience improvement within hours to days, rather than the weeks or months often required by traditional antidepressants.
Supervised Treatment
Each session is conducted in our certified clinic under medical supervision. The nasal spray is self-administered while our team monitors you for safety.
Ready to Explore SPRAVATO Treatment?
If you have been struggling with treatment-resistant depression, our team can help determine if SPRAVATO is the right option for you. Schedule a consultation today.
Book an Appointment